Title:
HETEROCYCLIC ESTERS OR AMIDES FOR VISION AND MEMORY DISORDERS
Document Type and Number:
WIPO Patent Application WO2000009112
Kind Code:
A3
Abstract:
This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance using heterocyclic esters and amides.
Inventors:
ROSS DOUGLAS T
SAUER HANSJORG
HAMILTON GREGORY S
STEINER JOSEPH P
SAUER HANSJORG
HAMILTON GREGORY S
STEINER JOSEPH P
Application Number:
PCT/US1999/018326
Publication Date:
June 29, 2000
Filing Date:
August 12, 1999
Export Citation:
Assignee:
GUILFORD PHARM INC (US)
International Classes:
C07D211/60; A61K31/00; A61K31/40; A61K31/415; A61K31/425; A61K31/44; A61K31/4427; A61K31/4439; A61K31/445; A61K31/495; A61K31/535; A61K31/54; A61P27/00; A61P27/12; C07D207/16; C07D401/06; C07D401/12; C07D417/12; (IPC1-7): A61K31/44; A61K31/00; A61K31/40; A61K31/415; A61K31/425; A61K31/495; A61K31/535; A61K31/54
Domestic Patent References:
| WO1998013355A1 | 1998-04-02 | |||
| WO1996040140A1 | 1996-12-19 | |||
| WO1997016190A1 | 1997-05-09 | |||
| WO1992019278A1 | 1992-11-12 | |||
| WO1992000278A1 | 1992-01-09 | |||
| WO1998013343A1 | 1998-04-02 | |||
| WO1996041609A2 | 1996-12-27 | |||
| WO1992021313A2 | 1992-12-10 | |||
| WO1998020893A1 | 1998-05-22 | |||
| WO1998037882A1 | 1998-09-03 | |||
| WO1998055091A1 | 1998-12-10 | |||
| WO1998037885A1 | 1998-09-03 | |||
| WO1998041205A1 | 1998-09-24 | |||
| WO1999042104A1 | 1999-08-26 | |||
| WO1999045006A1 | 1999-09-10 |
Foreign References:
| EP0484936A1 | 1992-05-13 | |||
| US5721256A | 1998-02-24 | |||
| US5541193A | 1996-07-30 | |||
| EP0509753A1 | 1992-10-21 | |||
| US5252579A | 1993-10-12 | |||
| EP0356399A2 | 1990-02-28 | |||
| DE4039587A1 | 1992-06-17 |
Other References:
KAWASHIMA ET AL.: "Effects of a new immunospuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats", INVEST. OPHTHALMOL. VIS. SCI., vol. 29, 1988, pages 1265 - 1271, XP000856700
ROSS ET AL.: "The FKBP neuroimmunophilin lignand GPI-1046 enhances retinal ganglion cell survival and arrests axonal dying back following optic nerve transection", SOC. NEUROSCI. ABSTR., vol. 24, no. 1-2, 7 November 1998 (1998-11-07) - 12 November 1998 (1998-11-12), pages 814, XP000856019
ROSS ET AL.: "The FKBP neuroimmunophilin lignand GPI-1046 enhances retinal ganglion cell survival and arrests axonal dying back following optic nerve transection", SOC. NEUROSCI. ABSTR., vol. 24, no. 1-2, 7 November 1998 (1998-11-07) - 12 November 1998 (1998-11-12), pages 814, XP000856019
Download PDF: